Linus Jonsson
Overview
Explore the profile of Linus Jonsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
3804
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wallensten J, Wachtler C, Bogdanovic N, Olofsson A, Kivipelto M, Jonsson L, et al.
J Prev Alzheimers Dis
. 2025 Mar;
:100115.
PMID: 40057461
Background: Integrating machine learning with medical records offers potential for early detection of Alzheimer's disease (AD), enabling timely interventions. Objectives: This study aimed to evaluate the effectiveness of machine learning...
2.
Umoh I, Xia X, Winblad B, Aye S, Aho E, Rhodius-Meester H, et al.
Dement Geriatr Cogn Disord
. 2025 Feb;
:1-17.
PMID: 39999809
Introduction: Technological advancements like digital monitoring tools, disease modifying therapies and artificial intelligence have been shown to improve the clinical management of neurocognitive diseases like Alzheimer's disease (AD). To enhance...
3.
Jonsson L, Wibom M, Londos E, Nagga K
Alzheimers Dement (N Y)
. 2025 Feb;
11(1):e70057.
PMID: 39995597
Introduction: Behavioral and psychological symptoms of dementia (BPSD) are a common driver of suffering and high care needs. We describe the Swedish BPSD registry, founded in 2010 to develop an...
4.
Li Y, Jonsson L
Cereb Circ Cogn Behav
. 2025 Feb;
8:100377.
PMID: 39897094
Brain disorders are prevalent across all age groups but particularly in the elderly, highlighting the importance of preserving brain health in ageing populations. There have been few previous studies to...
5.
Kim K, Sweeting M, Jonsson L, Wilking N
Thorac Cancer
. 2025 Jan;
16(1):e15535.
PMID: 39806827
Background: The long-term real-world effect of immunotherapy (IO) is uncertain in metastatic nonsmall cell lung cancer (mNSCLC). This retrospective observational study aimed to describe treatment patterns following the introduction of...
6.
Aye S, Johansson G, Hock C, Lannfelt L, Sims J, Blennow K, et al.
J Prev Alzheimers Dis
. 2025 Jan;
12(1):100022.
PMID: 39800469
The advancement of disease-modifying treatments (DMTs) for Alzheimer's disease (AD), along with the approval of three amyloid-targeting therapies in the US and several other countries, represents a significant development in...
7.
Handels R, Hataiyusuk S, Wimo A, Skoldunger A, Bakker C, Bieber A, et al.
J Prev Alzheimers Dis
. 2025 Jan;
12(1):100015.
PMID: 39800459
Introduction: Informal care estimates for use in health-economic models are lacking. We aimed to estimate the association between informal care time and dementia symptoms across Europe. Methods: A secondary analysis...
8.
Schiel A, Brogaard N, Hahn-Pedersen J, Schlueter M, Jonsson L
Alzheimer Dis Assoc Disord
. 2025 Jan;
PMID: 39790094
No abstract available.
9.
van Gils A, Tolonen A, Van Harten A, Vigneswaran S, Barkhof F, Visser L, et al.
Alzheimers Res Ther
. 2024 Nov;
16(1):256.
PMID: 39587679
Background: The increasing prevalence of dementia and the introduction of disease-modifying therapies (DMTs) highlight the need for efficient diagnostic pathways in memory clinics. We present a data-driven approach to efficiently...
10.
Zhou R, Duell F, Axenhus M, Jonsson L, Winblad B, Tjernberg L, et al.
Brain Commun
. 2024 Nov;
6(6):fcae371.
PMID: 39494362
Early detection of Alzheimer's disease is vital for timely treatment. Existing biomarkers for Alzheimer's disease reflect amyloid- and tau-related pathology, but it is unknown whether the disease can be detected...